BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18156313)

  • 1. Midazolam metabolism in cytochrome P450 3A knockout mice can be attributed to up-regulated CYP2C enzymes.
    van Waterschoot RA; van Herwaarden AE; Lagas JS; Sparidans RW; Wagenaar E; van der Kruijssen CM; Goldstein JA; Zeldin DC; Beijnen JH; Schinkel AH
    Mol Pharmacol; 2008 Mar; 73(3):1029-36. PubMed ID: 18156313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-drug interactions and metabolism in cytochrome P450 2C knockout mice: application to troleandomycin and midazolam.
    Grimsley A; Gallagher R; Hutchison M; Pickup K; Wilson ID; Samuelsson K
    Biochem Pharmacol; 2013 Aug; 86(4):529-38. PubMed ID: 23732297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein, multidrug-resistance associated protein 2, Cyp3a, and carboxylesterase affect the oral availability and metabolism of vinorelbine.
    Lagas JS; Damen CW; van Waterschoot RA; Iusuf D; Beijnen JH; Schinkel AH
    Mol Pharmacol; 2012 Oct; 82(4):636-44. PubMed ID: 22767610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the hepatic metabolism of triazolam in wild-type andCyp3a-knockout mice for understanding CYP3A-mediated metabolism inCYP3A-humanised mice
    Minegishi G; Kazuki Y; Yamasaki Y; Okuya F; Akita H; Oshimura M; Kobayashi K
    Xenobiotica; 2019 Nov; 49(11):1303-1310. PubMed ID: 30561249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
    Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
    Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential metabolism of midazolam in mouse liver and intestine microsomes: a comparison of cytochrome P450 activity and expression.
    Perloff MD; Von Moltke LL; Greenblatt DJ
    Xenobiotica; 2003 Apr; 33(4):365-77. PubMed ID: 12745872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone.
    Mäenpää J; Hall SD; Ring BJ; Strom SC; Wrighton SA
    Pharmacogenetics; 1998 Apr; 8(2):137-55. PubMed ID: 10022752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal cytochrome P450 3A plays an important role in the regulation of detoxifying systems in the liver.
    van Waterschoot RA; Rooswinkel RW; Wagenaar E; van der Kruijssen CM; van Herwaarden AE; Schinkel AH
    FASEB J; 2009 Jan; 23(1):224-31. PubMed ID: 18794335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo and in-vitro metabolic clearance of midazolam, a cytochrome P450 3A substrate, by the liver under normal and increased enzyme activity in rats.
    Higashikawa F; Murakami T; Kaneda T; Takano M
    J Pharm Pharmacol; 1999 Apr; 51(4):405-10. PubMed ID: 10385212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.
    Tsunoda SM; Velez RL; von Moltke LL; Greenblatt DJ
    Clin Pharmacol Ther; 1999 Nov; 66(5):461-71. PubMed ID: 10579473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Study Design Using Continuous Intravenous and Intraduodenal Infusions of Midazolam and Voriconazole for Mechanistic Quantitative Assessment of Hepatic and Intestinal CYP3A Inhibition.
    Li X; Junge L; Taubert M; von Georg A; Dahlinger D; Starke C; Frechen S; Stelzer C; Kinzig M; Sörgel F; Jaehde U; Töx U; Goeser T; Fuhr U
    J Clin Pharmacol; 2020 Sep; 60(9):1237-1253. PubMed ID: 32427354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2C and CYP2B Mediated Metabolic Activation of Retrorsine in Cyp3a Knockout Mice.
    Pang X; Tang C; Kong F; Chen M; Chen X
    Curr Drug Metab; 2020; 21(13):1040-1051. PubMed ID: 33267758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes.
    Perloff MD; von Moltke LL; Cotreau MM; Greenblatt DJ
    Biochem Pharmacol; 1999 Jun; 57(11):1227-32. PubMed ID: 10230766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short communication: insulin alters hepatic progesterone catabolic enzymes cytochrome P450 2C and 3A in dairy cows.
    Lemley CO; Butler ST; Butler WR; Wilson ME
    J Dairy Sci; 2008 Feb; 91(2):641-5. PubMed ID: 18218751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of age on in vitro midazolam biotransformation in male CD-1 mouse liver microsomes.
    Warrington JS; Poku JW; von Moltke LL; Shader RI; Harmatz JS; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1024-31. PubMed ID: 10688619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of 30 murine cytochrome p450 genes results in viable mice with compromised drug metabolism.
    Scheer N; McLaughlin LA; Rode A; Macleod AK; Henderson CJ; Wolf CR
    Drug Metab Dispos; 2014 Jun; 42(6):1022-30. PubMed ID: 24671958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam.
    van Waterschoot RA; Rooswinkel RW; Sparidans RW; van Herwaarden AE; Beijnen JH; Schinkel AH
    Drug Metab Dispos; 2009 Dec; 37(12):2305-13. PubMed ID: 19752211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies.
    Hamaoka N; Oda Y; Hase I; Asada A
    Br J Anaesth; 2001 Apr; 86(4):540-4. PubMed ID: 11573629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo inhibition of CYP3A-mediated midazolam metabolism by anchusan in rats.
    Saito Y; Nishimura Y; Kurata N; Iwase M; Aoki K; Yasuhara H
    J Pharmacol Sci; 2011; 115(3):399-407. PubMed ID: 21358120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midazolam is metabolized by at least three different cytochrome P450 enzymes.
    Wandel C; Böcker R; Böhrer H; Browne A; Rügheimer E; Martin E
    Br J Anaesth; 1994 Nov; 73(5):658-61. PubMed ID: 7826796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.